BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 27416006)

  • 1. How genetic testing can lead to targeted management of XIAP deficiency-related inflammatory bowel disease.
    Nielsen OH; LaCasse EC
    Genet Med; 2017 Feb; 19(2):133-143. PubMed ID: 27416006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. XIAP deficiency syndrome in humans.
    Latour S; Aguilar C
    Semin Cell Dev Biol; 2015 Mar; 39():115-23. PubMed ID: 25666262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency.
    Wada T; Kanegane H; Ohta K; Katoh F; Imamura T; Nakazawa Y; Miyashita R; Hara J; Hamamoto K; Yang X; Filipovich AH; Marsh RA; Yachie A
    Cytokine; 2014 Jan; 65(1):74-8. PubMed ID: 24084330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic.
    Xu T; Zhao Q; Li W; Chen X; Xue X; Chen Z; Du X; Bai X; Zhao Q; Zhou L; Tang X; Yang X; Kanegane H; Zhao X
    Eur J Pediatr; 2020 Feb; 179(2):327-338. PubMed ID: 31754776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers.
    Aguilar C; Lenoir C; Lambert N; Bègue B; Brousse N; Canioni D; Berrebi D; Roy M; Gérart S; Chapel H; Schwerd T; Siproudhis L; Schäppi M; Al-Ahmari A; Mori M; Yamaide A; Galicier L; Neven B; Routes J; Uhlig HH; Koletzko S; Patel S; Kanegane H; Picard C; Fischer A; Bensussan NC; Ruemmele F; Hugot JP; Latour S
    J Allergy Clin Immunol; 2014 Nov; 134(5):1131-41.e9. PubMed ID: 24942515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-related hemophagocytic lymphohistiocytosis complicated with coronary artery dilation and acute renal injury in a boy with a novel X-linked inhibitor of apoptosis protein (XIAP) variant: a case report.
    Chen RY; Li XZ; Lin Q; Zhu Y; Shen YY; Xu QY; Zhu XM; Bai ZJ; Li Y
    BMC Pediatr; 2020 Oct; 20(1):456. PubMed ID: 33008347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency.
    Marsh RA; Bleesing JJ; Filipovich AH
    J Immunol Methods; 2010 Oct; 362(1-2):1-9. PubMed ID: 20816973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-Linked Lymphoproliferative Syndrome: A Spectrum of Clinical and Immunological Profile and Novel Pathogenic Variants from Chandigarh, India.
    Jindal AK; Mondal S; Sil A; Rawat A; Chawla S; Tyagi R; Sudhakar M; Banday AZ; Suri D; Vignesh P; Dhaliwal M; Sharma S; Rikhi R; Saka R; Sharma R; Chatterjee D; Sreedharanunni S; Uppuluri R; Raj R; Singh S
    Int Arch Allergy Immunol; 2024; 185(4):370-381. PubMed ID: 38194943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAP and XIAP deficiency in hemophagocytic lymphohistiocytosis.
    Yang X; Miyawaki T; Kanegane H
    Pediatr Int; 2012 Aug; 54(4):447-54. PubMed ID: 22672194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome.
    Rigaud S; Fondanèche MC; Lambert N; Pasquier B; Mateo V; Soulas P; Galicier L; Le Deist F; Rieux-Laucat F; Revy P; Fischer A; de Saint Basile G; Latour S
    Nature; 2006 Nov; 444(7115):110-4. PubMed ID: 17080092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome.
    Aguilar C; Latour S
    J Clin Immunol; 2015 May; 35(4):331-8. PubMed ID: 25737324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk-factors Associated With Poor Outcomes in VEO-IBD Secondary to XIAP Deficiency: A Case Report and Literature Review.
    Lekbua A; Ouahed J; O'Connell AE; Kahn SA; Goldsmith JD; Imamura T; Duncan CN; Kelsen JR; Worthey E; Snapper SB; Softic S
    J Pediatr Gastroenterol Nutr; 2019 Jul; 69(1):e13-e18. PubMed ID: 31232887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
    Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
    Front Pediatr; 2019; 7():183. PubMed ID: 31231620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid flow cytometric screening test for X-linked lymphoproliferative disease due to XIAP deficiency.
    Marsh RA; Villanueva J; Zhang K; Snow AL; Su HC; Madden L; Mody R; Kitchen B; Marmer D; Jordan MB; Risma KA; Filipovich AH; Bleesing JJ
    Cytometry B Clin Cytom; 2009 Sep; 76(5):334-44. PubMed ID: 19288545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleotide-binding oligomerization domain (NOD) signaling defects and cell death susceptibility cannot be uncoupled in X-linked inhibitor of apoptosis (XIAP)-driven inflammatory disease.
    Chirieleison SM; Marsh RA; Kumar P; Rathkey JK; Dubyak GR; Abbott DW
    J Biol Chem; 2017 Jun; 292(23):9666-9679. PubMed ID: 28404814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis.
    Speckmann C; Lehmberg K; Albert MH; Damgaard RB; Fritsch M; Gyrd-Hansen M; Rensing-Ehl A; Vraetz T; Grimbacher B; Salzer U; Fuchs I; Ufheil H; Belohradsky BH; Hassan A; Cale CM; Elawad M; Strahm B; Schibli S; Lauten M; Kohl M; Meerpohl JJ; Rodeck B; Kolb R; Eberl W; Soerensen J; von Bernuth H; Lorenz M; Schwarz K; Zur Stadt U; Ehl S
    Clin Immunol; 2013 Oct; 149(1):133-41. PubMed ID: 23973892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [X-linked inhibitor of apoptosis deficiency manifested as Crohn's disease: a case report and literature review].
    Xu LJ; Luo YY; Yu JD; Lou JG; Fang YH; Chen J
    Zhonghua Er Ke Za Zhi; 2018 Jan; 56(1):43-47. PubMed ID: 29342997
    [No Abstract]   [Full Text] [Related]  

  • 18. Hematopoietic Cell Transplantation Rescues Inflammatory Bowel Disease and Dysbiosis of Gut Microbiota in XIAP Deficiency.
    Ono S; Takeshita K; Kiridoshi Y; Kato M; Kamiya T; Hoshino A; Yanagimachi M; Arai K; Takeuchi I; Toita N; Imamura T; Sasahara Y; Sugita J; Hamamoto K; Takeuchi M; Saito S; Onuma M; Tsujimoto H; Yasui M; Taga T; Arakawa Y; Mitani Y; Yamamoto N; Imai K; Suda W; Hattori M; Ohara O; Morio T; Honda K; Kanegane H
    J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3767-3780. PubMed ID: 34246792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Sequencing and Immunological Analysis Reveal the Involvement of Primary Immunodeficiency Genes in Pediatric IBD: a Japanese Multicenter Study.
    Suzuki T; Sasahara Y; Kikuchi A; Kakuta H; Kashiwabara T; Ishige T; Nakayama Y; Tanaka M; Hoshino A; Kanegane H; Abukawa D; Kure S
    J Clin Immunol; 2017 Jan; 37(1):67-79. PubMed ID: 27747465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease.
    Marsh RA; Madden L; Kitchen BJ; Mody R; McClimon B; Jordan MB; Bleesing JJ; Zhang K; Filipovich AH
    Blood; 2010 Aug; 116(7):1079-82. PubMed ID: 20489057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.